Emerging 2019 novel coronavirus (2019-nCoV) pneumonia F Song, N Shi, F Shan, Z Zhang, J Shen, H Lu, Y Ling, Y Jiang, Y Shi Radiology 295 (1), 210-217, 2020 | 1736 | 2020 |
A pilot study of hydroxychloroquine in treatment of patients with common C Jun, L Danping, L Li, L Ping, X Qingnian, X Lu, L Yun Zhejiang Da Xue Xue Bao Yi Xue Ban 25 (49), 2, 2020 | 1015 | 2020 |
Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Y Ling, SB Xu, YX Lin, D Tian, ZQ Zhu, FH Dai, F Wu, ZG Song, W Huang, ... Chinese medical journal 133 (09), 1039-1043, 2020 | 1006 | 2020 |
COVID-19 with different severities: a multicenter study of clinical features Y Feng, Y Ling, T Bai, Y Xie, J Huang, J Li, W Xiong, D Yang, R Chen, ... American journal of respiratory and critical care medicine 201 (11), 1380-1388, 2020 | 996 | 2020 |
Viral and host factors related to the clinical outcome of COVID-19 X Zhang, Y Tan, Y Ling, G Lu, F Liu, Z Yi, X Jia, M Wu, B Shi, S Xu, J Chen, ... Nature 583 (7816), 437-440, 2020 | 973 | 2020 |
Clinical progression of patients with COVID-19 in Shanghai, China J Chen, T Qi, L Liu, Y Ling, Z Qian, T Li, F Li, Q Xu, Y Zhang, S Xu, Z Song, ... Journal of infection 80 (5), e1-e6, 2020 | 971 | 2020 |
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications F Wu, A Wang, M Liu, Q Wang, J Chen, S Xia, Y Ling, Y Zhang, J Xun, ... MedRxiv, 2020 | 787 | 2020 |
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas X Ren, W Wen, X Fan, W Hou, B Su, P Cai, J Li, Y Liu, F Tang, F Zhang, ... Cell 184 (7), 1895-1913. e19, 2021 | 766 | 2021 |
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey MO Chandesris, I Melki, A Natividad, A Puel, C Fieschi, L Yun, ... Medicine 91 (4), e1-e19, 2012 | 357 | 2012 |
Evaluating the association of clinical characteristics with neutralizing antibody levels in patients who have recovered from mild COVID-19 in Shanghai, China F Wu, M Liu, A Wang, L Lu, Q Wang, C Gu, J Chen, Y Wu, S Xia, Y Ling, ... JAMA internal medicine 180 (10), 1356-1362, 2020 | 252 | 2020 |
Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis Y Ling, S Cypowyj, C Aytekin, M Galicchio, Y Camcioglu, S Nepesov, ... Journal of Experimental Medicine 212 (5), 619-631, 2015 | 212 | 2015 |
Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage YM Chen, Y Zheng, Y Yu, Y Wang, Q Huang, F Qian, L Sun, ZG Song, ... The EMBO journal 39 (24), e105896, 2020 | 178 | 2020 |
Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency R Lévy, S Okada, V Béziat, K Moriya, C Liu, LYA Chai, M Migaud, F Hauck, ... Proceedings of the National Academy of Sciences 113 (51), E8277-E8285, 2016 | 172 | 2016 |
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 169 | 2022 |
Antiviral activity and safety of darunavir/cobicistat for the treatment of COVID-19 J Chen, L Xia, L Liu, Q Xu, Y Ling, D Huang, W Huang, S Song, S Xu, ... Open forum infectious diseases 7 (7), ofaa241, 2020 | 158 | 2020 |
Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients N Wu, J Dai, M Guo, J Li, X Zhou, F Li, Y Gao, H Qu, H Lu, J Jin, T Li, L Shi, ... Emerging microbes & infections 10 (1), 612-618, 2021 | 132 | 2021 |
Dual T cell– and B cell–intrinsic deficiency in humans with biallelic RLTPR mutations Y Wang, CS Ma, Y Ling, A Bousfiha, Y Camcioglu, S Jacquot, K Payne, ... Journal of Experimental Medicine 213 (11), 2413-2435, 2016 | 125 | 2016 |
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia Q Zhang, D Matuozzo, J Le Pen, D Lee, L Moens, T Asano, J Bohlen, ... Journal of Experimental Medicine 219 (8), 2022 | 111 | 2022 |
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study J Liu, X Pan, S Zhang, M Li, K Ma, C Fan, Y Lv, X Guan, Y Yang, X Ye, ... The Lancet Regional Health–Western Pacific 33, 2023 | 97 | 2023 |
Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations XH Li, Y Lu, Y Ling, QC Fu, J Xu, GQ Zang, F Zhou, Y De-Min, Y Han, ... BMC medical genetics 12, 1-13, 2011 | 91 | 2011 |